| 0 | ℹ |
Reprogramming HER2-Positive gastroesophageal cancer immune contexture with bispecific therapy: HERIZON-GEA-01.
(linkinghub.elsevier.com)
|
Cell Med 2026-08-14 | #cancer #immunotherapy #bispecific #gastroesophageal #her2 |